Recombinant human C1 inhibitor (Santarus)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human C1 inhibitor (Santarus)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionComplement C1s inhibitors

TargetsComplement C1s

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSantarus Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSantarus Inc

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A